Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
16.55
+0.06 (0.36%)
Jun 8, 2026, 12:18 PM EDT - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $4.68 billion as of June 8, 2026.
Market Cap
4.68B
Enterprise Value
4.42B
1-Year Change
n/a
Ranking
Category
Stock Price
$16.55
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $4.68B, a decrease of -21.43%. That is a compound annual growth rate of -22.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 4.66B | -38.77% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 5.64B |
| Scholar Rock Holding | 5.31B |
| Cogent Biosciences | 5.30B |
| Xenon Pharmaceuticals | 5.00B |
| CRISPR Therapeutics AG | 5.00B |
| Ligand Pharmaceuticals | 4.75B |
| CG Oncology | 4.74B |
| Dianthus Therapeutics | 4.40B |